
DeepScribe
An artificially intelligent clinical documentation tool that autonomously prepares complete SOAP notes.
USD | 2021 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
DeepScribe operates in the healthcare technology sector, providing AI-powered medical scribe services designed to transform patient conversations into detailed, customizable clinical notes. The company serves healthcare providers, including doctors and clinics, by leveraging advanced speech recognition technology to capture clinical conversations with extreme accuracy. This allows clinicians to focus more on patient care rather than documentation. DeepScribe's business model is subscription-based, where clients pay for access to the AI scribe service. The company generates revenue through these subscriptions, offering various tiers of service based on the needs of the healthcare providers. DeepScribe also emphasizes trust and safety, promoting AI transparency and interpretability to ensure the accuracy and reliability of its services. The market it operates in is the medical transcription and documentation sector, which is increasingly adopting AI solutions to improve efficiency and reduce administrative burdens on healthcare professionals.
Keywords: AI medical scribe, healthcare technology, speech recognition, clinical notes, patient care, subscription model, documentation, transparency, accuracy, efficiency.